Search research articles
Contact Us
Filters
Showing results (1-10 of 169) with videos related to
Page
of 17
Sort By:
Clinical Medicine Insights. Oncology
|
December 3, 2015
Obesity Correlation With Metastases Development and Response to First-Line Metastatic Chemotherapy in Breast Cancer
Mohammed A Osman, Bryan T Hennessy
Drugs
|
June 15, 2011
Molecular targeted therapy in ovarian cancer: what is on the horizon?
Roshni Kalachand, Bryan T Hennessy, Maurie Markman
Lancet (London, England)
|
October 2, 2009
Ovarian cancer
Bryan T Hennessy, Robert L Coleman, Maurie Markman
Molecular Biology Reports
|
June 28, 2024
Chromosomal copy number and mutational status are required to authenticate ovarian cancer cell lines as appropriate cell models
Britta Stordal, Angela M Farrelly, Bryan T Hennessy
Expert Opinion on Pharmacotherapy
|
August 10, 2005
Neoadjuvant systemic therapy for breast cancer: an overview and review of recent clinical trials
Emer O Hanrahan, Bryan T Hennessy, Vicente Valero
Frontiers in Endocrinology
|
April 19, 2021
New Roles for Vitamin D Superagonists: From COVID to Cancer
David J Easty, Christine J Farr, Bryan T Hennessy
The Journal of Clinical Investigation
|
April 15, 2011
Next-generation mTOR inhibitors in clinical oncology: how pathway complexity informs therapeutic strategy
Seth A Wander, Bryan T Hennessy, Joyce M Slingerland
The Lancet. Oncology
|
June 3, 2004
Non-Hodgkin lymphoma: an update
Bryan T Hennessy, Emer O Hanrahan, Peter A Daly
Cancer Microenvironment : Official Journal of the International Cancer Microenvironment Society
|
October 19, 2014
Immune effects of bevacizumab: killing two birds with one stone
Yasir Y Elamin, Shereen Rafee, Sinead Toomey, et al.
Nature Clinical Practice. Oncology
|
December 13, 2005
Individualization of neoadjuvant therapy for breast cancer according to molecular tumor characteristics
Bryan T Hennessy, Ana Maria Gonzalez-Angulo, Gabriel N Hortobagyi
Page
of 17
Search research articles
Search
Showing results (1-10 of 169) with videos related to
Sort By:
Page
of 17
Clinical Medicine Insights. Oncology
|
December 3, 2015
Obesity Correlation With Metastases Development and Response to First-Line Metastatic Chemotherapy in Breast Cancer
Mohammed A Osman, Bryan T Hennessy
Drugs
|
June 15, 2011
Molecular targeted therapy in ovarian cancer: what is on the horizon?
Roshni Kalachand, Bryan T Hennessy, Maurie Markman
Lancet (London, England)
|
October 2, 2009
Ovarian cancer
Bryan T Hennessy, Robert L Coleman, Maurie Markman
Molecular Biology Reports
|
June 28, 2024
Chromosomal copy number and mutational status are required to authenticate ovarian cancer cell lines as appropriate cell models
Britta Stordal, Angela M Farrelly, Bryan T Hennessy
Expert Opinion on Pharmacotherapy
|
August 10, 2005
Neoadjuvant systemic therapy for breast cancer: an overview and review of recent clinical trials
Emer O Hanrahan, Bryan T Hennessy, Vicente Valero
Frontiers in Endocrinology
|
April 19, 2021
New Roles for Vitamin D Superagonists: From COVID to Cancer
David J Easty, Christine J Farr, Bryan T Hennessy
The Journal of Clinical Investigation
|
April 15, 2011
Next-generation mTOR inhibitors in clinical oncology: how pathway complexity informs therapeutic strategy
Seth A Wander, Bryan T Hennessy, Joyce M Slingerland
The Lancet. Oncology
|
June 3, 2004
Non-Hodgkin lymphoma: an update
Bryan T Hennessy, Emer O Hanrahan, Peter A Daly
Cancer Microenvironment : Official Journal of the International Cancer Microenvironment Society
|
October 19, 2014
Immune effects of bevacizumab: killing two birds with one stone
Yasir Y Elamin, Shereen Rafee, Sinead Toomey, et al.
Nature Clinical Practice. Oncology
|
December 13, 2005
Individualization of neoadjuvant therapy for breast cancer according to molecular tumor characteristics
Bryan T Hennessy, Ana Maria Gonzalez-Angulo, Gabriel N Hortobagyi
Page
of 17